Steps to Start Connect with us via email or call Choose your desired territory Discuss the product pricing and marketing support Finalize the agreement and get started FAQs 1
Likewise, 70 participants self-reported using tirzepatide, of whom 85.7% had a corroborating EHR record
At the highest dose of 12 mg weekly, participants averaged 24.2% weight loss
If your Aetna plan includes a weight loss or anti-obesity medication benefit, these drugs are more likely to be covered
Work with pharmacology and gastroenterology experts to explain how GLP-1-induced delayed gastric emptying or biliary stasis can lead to obstruction, pancreatitis, or cholecystitis
It is possible such a group may reduce alcohol consumption even without taking GLP-1s, when compared to a sample of the general population